The University of Warwick Library - WebBridge

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2) : a randomised, double-blind, placebo-controlled trial
Raal, Frederick J.  The Lancet.  v. 385. no. 9965.   2015-01-24. p. 331 - 340... issn: 0140-6736 .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.